Article Information
History
- January 16, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Ian R. Outhwaite1,
- Sukrit Singh1,2,
- Benedict-Tilman Berger3,4,
- Stefan Knapp3,4,
- John D. Chodera2 and
- Markus A. Seeliger1,†
- 1Department of Pharmacological Sciences, Stony Brook University, Stony Brook, NY 11794
- 2Computational and Systems Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065
- 3Institute of Pharmaceutical Chemistry, Goethe University Frankfurt, Frankfurt am Main, Germany
- 4Structural Genomics Consortium, Buchmann Institute for Life Sciences, Goethe University Frankfurt, Frankfurt am Main, Germany
- ↵†To whom correspondence should be sent: Markus Seeliger, Phone: (631) 444-3558, E-mail: markus.seeliger{at}stonybrook.edu
Posted January 16, 2023.
Death by a Thousand Cuts – Combining Kinase Inhibitors for Selective Target Inhibition and Rational Polypharmacology
